<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02506439</url>
  </required_header>
  <id_info>
    <org_study_id>ODINWP4DMAT</org_study_id>
    <nct_id>NCT02506439</nct_id>
  </id_info>
  <brief_title>Nutritional Requirements for Vitamin D in Pregnant Women</brief_title>
  <acronym>DMAT</acronym>
  <official_title>Randomized Controlled Trial to Determine the Nutritional Requirement for Vitamin D for Prevention of Deficiency During Pregnancy and in the Early Neonatal Period (D-MAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mairead Kiely PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Cork</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised, placebo-controlled dose-response intervention study with vitamin D3 in pregnant
      women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a three-arm, parallel, double-blind, placebo-controlled dose-response intervention
      study with vitamin D3. Women will be recruited prior to 18 weeks of gestation and randomised
      to receive placebo, 10 or 20 mcg/d of vitamin D3 from baseline visit in their first trimester
      until delivery. Blood samples will be collected at baseline, midpoint and endpoint of the
      trial, at 10 week intervals, and from the umbilical cord at delivery. A 25-hydroxyvitamin D
      concentration of 30 nmol/L will be used to denote vitamin D deficiency. Information on
      maternal anthropometry, diet, lifestyle, sun exposure, blood pressure, iPTH and serum total
      calcium will also be reported.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2014</start_date>
  <completion_date type="Actual">April 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum 25-hydroxyvitamin D in pregnant women and cord blood</measure>
    <time_frame>Change from 1st through 2nd trimester and at delivery</time_frame>
    <description>Analysis of serum 25-hydroxyvitamin D in mothers for blood taken in the first, second and third trimesters and in umbilical cord</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum total calcium</measure>
    <time_frame>Change from 1st through 2nd trimester and at delivery</time_frame>
    <description>Analysis of serum total calcium (adjusted for albumin) in mothers for blood taken in the first, second and third trimesters and in umbilical cord</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal blood pressure during pregnancy</measure>
    <time_frame>Change from 1st through 2nd trimester and at delivery</time_frame>
    <description>Blood pressure measurements will be taken in the first, second and third trimesters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Parathyroid Hormone</measure>
    <time_frame>Change from 1st through 2nd trimester and at delivery</time_frame>
    <description>Analysis of serum PTH in mothers for blood taken in the first, second and third trimesters and in umbilical cord</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>10 mcg Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>White-skinned women will receive Cholecalciferol (Vitamin D3) 10 mcg [400 IU] daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 mcg Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>White-skinned women will receive Cholecalciferol (Vitamin D3) 20 mcg [800 IU] daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>White-skinned women will receive a Placebo supplement, identical in appearance and taste to the active product</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10 mcg Vitamin D3</intervention_name>
    <description>Once daily, 10mcg (400IU) dose of vitamin D3 taken from baseline visit (approx 15 weeks gestation) until endpoint (delivery)</description>
    <arm_group_label>10 mcg Vitamin D3</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>20 mcg Vitamin D3</intervention_name>
    <description>Once daily, 20mcg (800IU) dose of vitamin D3 taken from baseline visit (approx 15 weeks gestation) until endpoint (delivery)</description>
    <arm_group_label>20 mcg Vitamin D3</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Once daily, placebo capsule containing 0mcg (0IU) of vitamin D3 taken from baseline visit (approx 15 weeks gestation) until endpoint (delivery)</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo capsule</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt;18 years)

          -  No more than 18 weeks gestation

          -  In good general health

          -  Low risk pregnancy

          -  Not consuming &gt;10 mcg/d vitamin D from supplements

        Exclusion Criteria:

          -  Current smokers

          -  Diagnosed hypertension

          -  Known high-risk pregnancy

          -  Diagnosed medical illness including diabetes mellitus (Types 1 &amp; 2), chronic kidney
             disease or gastro-intestinal diseases or any illness known to interfere with calcium
             metabolism (e.g. sarcoidosis).

          -  Consumption of medications known to interfere with vitamin D metabolism

          -  Consumption of vitamin D (≥ 10 µg/day) or calcium (≥ 650 mg/d) supplements prior to
             randomization
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mairead Kiely, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College Cork</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cork University Maternity Hospital and University College Cork</name>
      <address>
        <city>Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Human Nutrition Resource Unit, School of Food and Nutritional Sciences, University College Cork</name>
      <address>
        <city>Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2015</study_first_submitted>
  <study_first_submitted_qc>July 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University College Cork</investigator_affiliation>
    <investigator_full_name>Mairead Kiely PhD</investigator_full_name>
    <investigator_title>Professor of Human Nutrition</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Cholecalciferol</keyword>
  <keyword>Dose-response</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Cord blood</keyword>
  <keyword>Serum 25-hydroxyvitamin D</keyword>
  <keyword>Vitamin D Deficiency</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Dietary intervention study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD may be considered, for vitamin D intake and 25(OH)D data. Please contact m.kiely@ucc.ie.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

